MiMedx Group, Inc.
Nasdaq MDXG · Marietta, GA
Works in Cardiovascular · Dermatology · Metabolic & endocrine · Musculoskeletal
MiMedx Group, Inc. is a clinical trial sponsor based in Marietta, GA, listed as Nasdaq MDXG. It has 2 active clinical trials with 245 planned participants, in Cardiovascular, Dermatology, Metabolic & endocrine and Musculoskeletal. Since 2021 it has completed 4 trials and stopped 2 early.
Trial track record · since 2021
Financials · Nasdaq MDXG
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about MiMedx Group, Inc
MiMedx Group, Inc is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 245 planned participants, in Cardiovascular, Dermatology, Metabolic & endocrine, Musculoskeletal. Since 2021 it has completed 4 trials and stopped 2 early.
MiMedx Group, Inc is based in Marietta, GA and is listed as Nasdaq MDXG. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with MiMedx Group, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2024-09-19.
Approve Suite is not affiliated with MiMedx Group, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.